Oncology & Cancer

FDA approves drug for PET imaging of prostate cancer

(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer, the agency ...

Oncology & Cancer

Evaluating the 'financial toxicity' of prostate cancer treatment

For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). ...

Oncology & Cancer

Gene donors at high risk for cancer received feedback

Researchers at the Estonian Genome Center at the University of Tartu studied how people at high risk for breast, ovarian or prostate cancer responded to the feedback of genetic findings. Gene donors who chose to receive results ...

Oncology & Cancer

Should men be concerned about prostate cancer?

Prostate cancer is the second-most diagnosed cancer in men after skin cancer. Approximately 1 of 9 men in the U.S. will get prostate cancer in his lifetime. Most men diagnosed with the disease won't die from it. More than ...

page 1 from 40